TITLE

Agreements/contracts

PUB. DATE
September 2008
SOURCE
Medical Device Daily;9/17/2008, Vol. 12 Issue 199, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the partnership of WellDoc Communications with AstraZeneca Pharmaceuticals to educate patients about the significance of their medicine in asthma control. Under its patient support program, AstraZeneca's respiratory franchise will use WellDoc's web- and mobile-based asthma solution. WellDoc is capitalizing on its successful mobile diabetes management software and is extending its platform to support other chronic conditions.
ACCESSION #
34417050

 

Related Articles

  • Industry Watch.  // AARC Times;Feb2009, Vol. 33 Issue 2, p72 

    This section offers news briefs concerning respiratory therapy in the U.S. MedImmune has started a Phase 1/2 clinical trial of a live, attenuated intranasal vaccine in children one to 12 months of age to help prevent severe respiratory syncytial virus (RSV) infections. PARI Pharma GmbH has...

  • AstraZeneca offers creative solutions for diverse suppliers.  // Diversity/Careers in Engineering & Information Technology;Dec2012-Jan2013, p58 

    The article focuses on the move of pharmaceutical firm AstraZeneca Pharmaceuticals LP to provide creative solutions for diverse suppliers. The firm's supplier diversity program was started by Zeneca Pharmaceuticals Group prior to its collaboration with Astra. It profiles Will Henry, senior...

  • Health notes. Soule, Alexander // Fairfield County Business Journal;3/21/2011, Vol. 47 Issue 12, p12 

    The article offers news briefs related to health in Connecticut including the AstraZeneca Pharmaceuticals L.P. settlement case marketing of the anti-psychotic drug Seroquel, the state is among the lowest ranked of Alzheimer mortality rate, and the issue of Health Net information security of its...

  • AZ adds live chat option to sites. M. A. // Medical Marketing & Media;Jun2011, Vol. 46 Issue 6, p24 

    The article reports on the new features of websites Crestor.com and PurplePill.com from Astrazeneca Pharmaceuticals LP.

  • WASHINGTON report.  // Health Data Management;Oct2010, Vol. 18 Issue 10, p16 

    This section offers news briefs related to medical informatics in the U.S., including the clearance given by the U.S. Food and Drug Administration to the mobile phone-based DiabetesManager System of WellDoc Communications Inc. and the publication of approved procedures by the National Institutes...

  • Asthma Disease Management. Kallstrom, Thomas J. // AARC Times;Apr2011, Vol. 35 Issue 4, p6 

    The article offers the insights on the common myths regarding asthma disease management. It says that asthma is a chronic lung disease that can not be outgrown, in which symptoms may not evident but the aggravating factor may not disappear. It states that the danders and not the long hair of...

  • Soriot's status update for AZ: It's complicated. M. A. // Medical Marketing & Media;Mar2013, Vol. 48 Issue 3, p12 

    The article offers the insights of AstraZeneca Pharmaceuticals LP chief executive officer (CEO) Pascal Soriot on the corporate culture of the pharmaceutical company.

  • AstraZeneca to cut 7,300 more jobs. Weinstein, Deborah // Medical Marketing & Media;Mar2012, Vol. 47 Issue 3, p15 

    The article reports on the plans of AstraZeneca Pharmaceuticals LP to eliminate 7,300 positions in the company in 2012 and notes the closure of research centers in Sodertalje, Sweden and Montreal, Canada.

  • CHAPTER 97: TOP-SELLING PHARMACEUTICAL PRODUCTS. Miller, Richard K.; Washington, Kelli // Healthcare Business Market Research Handbook;2013, p405 

    A list of the top-selling pharmaceutical products, ranked by U.S. sales in 2012, is presented Nexium from AstraZeneca Pharmaceuticals, Advair Diskus from GlaxoSmithKline and Enbrel from Amgen.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics